Asset Details
Do you wish to reserve the book?
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky
Do you wish to request the book?
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky
2025
Overview
Background
Efforts to scale up overdose education and naloxone distribution (OEND), an evidence-based practice for reducing opioid overdose mortality, was a major focus of the HEALing Communities Study (HCS). The aim of this analysis is to describe the qualitative perspectives of partner organizations regarding the impacts of implementing OEND in a state that used a naloxone “hub with many spokes” model for scaling up this strategy.
Methods
Small group (
n
= 20) and individual (
n
= 24) qualitative interviews were conducted with staff from 44 agencies in eight Kentucky counties that implemented OEND from April 2020 to June 2022. Interviews were conducted between 6 and 8 months after the end of the intervention. Initial deductive coding used the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) framework, and then additional inductive sub-coding focused on passages within the OEND Effectiveness code. Thematic analysis was then utilized to identify themes regarding the impacts of implementing OEND.
Results
Participants identified multi-level impacts of implementing OEND. At the individual-level, participants described lives being saved, greater access to naloxone for individuals served by the agency, reduced stigma toward OEND by clients, and greater client-level self-efficacy to respond to overdoses. Organizational impacts included improved staff readiness for overdose response, enhanced clinical relationships between staff and clients, and reduced staff stigma. Participants described positive impacts on their organizational networks and clients’ social networks. Community-level impacts included greater overall access and reduced stigma toward OEND.
Conclusions
These qualitative data revealed that staff from agencies involved in a community-wide effort to scale up OEND perceived multi-level benefits, including saving lives, reducing stigma, improving naloxone access, and enhancing staff and client readiness, while strengthening organizational and community networks.
Trial registration
ClinicalTrials.gov, NCT04111939. Registered 30 September 2019,
https://clinicaltrials.gov/ct2/show/NCT04111939
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Analysis
/ Clients
/ Drug Overdose - drug therapy
/ Drug Overdose - prevention & control
/ Drugs
/ Female
/ Healing
/ Humans
/ Kentucky
/ Male
/ Medicine
/ Naloxone
/ Naloxone - supply & distribution
/ Narcotic Antagonists - supply & distribution
/ Narcotic Antagonists - therapeutic use
/ Opiate Overdose - drug therapy
/ Opioids
/ Organizational communication
/ Organizational effectiveness
/ Overdose
/ Overdose education and naloxone distribution
/ Patient Education as Topic - organization & administration
/ Stigma
/ Teams
